Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.84 USD | +1.07% | +13.60% | -63.41% |
04-18 | MyMD Pharmaceuticals, Inc. Announces Resignation of Adam Kaplin as Chief Scientific Officer | CI |
04-09 | Wall Street Set to Open Slightly Higher as Investors Await Wednesday's Inflation Data | MT |
Sales 2022 | - | Sales 2023 | - | Capitalization | 13.17M 1.05B |
---|---|---|---|---|---|
Net income 2022 | -15M -1.2B | Net income 2023 | -4M -319M | EV / Sales 2022 | - |
Net cash position 2022 | 4.69M 375M | Net cash position 2023 | 4.87M 389M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.94
x | P/E ratio 2023 |
-1.46
x | Employees | 6 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 92.68% |
1 day | +1.07% | ||
1 week | +13.60% | ||
Current month | +18.83% | ||
1 month | +18.83% | ||
3 months | -39.59% | ||
6 months | -75.73% | ||
Current year | -63.41% |
Managers | Title | Age | Since |
---|---|---|---|
President | 71 | 31/10/20 | |
Ian Rhodes
DFI | Director of Finance/CFO | 51 | 14/04/21 |
Director/Board Member | 58 | 07/08/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 58 | 07/08/17 | |
President | 71 | 31/10/20 | |
Joshua Silverman
CHM | Chairman | 53 | 05/09/18 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 2.84 | +1.07% | 17,442 |
25/04/24 | 2.81 | -1.75% | 20,281 |
24/04/24 | 2.86 | +11.72% | 104,906 |
23/04/24 | 2.56 | -0.78% | 22,727 |
22/04/24 | 2.58 | +3.20% | 65,557 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-63.41% | 6.13M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- MYMD Stock